RT Book, Section
A1 Weisberg, Edmund
A1 Baumann, Leslie
A2 Baumann, Leslie
A2 Saghari, Sogol
A2 Weisberg, Edmund
SR Print(0)
ID 1172447520
T1 Cosmetic and Drug Regulation
T2 Cosmetic Dermatology: Principles and Practice, 2e
YR 2009
FD 2009
PB The McGraw-Hill Companies, Inc.
PP New York, NY
SN 9780071490627
LK dermatology.mhmedical.com/content.aspx?aid=1172447520
RD 2024/04/23
AB According  to  the  United  States  Food  and  Drug  Administration  (FDA),  a  personal  care  product  can  be  classified  as  a  drug,  a  cosmetic,  or  both.  Moisturizers  with  skin  protection  factor  (SPF)  and  antidandruff  shampoos  are  examples  of  dermatologic  products  classified  as  both  a  drug  and  a  cosmetic.  The  term  “cosmeceutical”  was  introduced  approximately  25  years  ago  by  Albert  Kligman,  MD,  at  a  meeting  of  the  Society  of  Cosmetic  Chemists  because  he  felt  that  a  new  category  of  regulation  should  exist.1  Although  this  topic  has  been  debated  for  decades,  the  category  “cosmeceuticals”  has  still  not  been  codified  or  officially  recognized.  In  other  words,  it  has  no  legal  meaning.  The  term,  however,  is  increasingly  a  part  of  the  mainstream  vernacular  and  frequently  used  to  describe  products  that  are  known  to  have  a  biologic  action  but  are  regulated  as  cosmetics  (e.g.,  products  containing  retinol).  Although  it  is  well  known  that  retinol  stimulates  retinoic  acid  receptors  resulting  in  biologic  activity,  retinol  is  a  popular  ingredient  contained  in  numerous  cosmetics.  Companies  often  list  retinol  as  an  inactive  ingredient  on  product  labels  to  avoid  regulatory  action  by  the  FDA.